DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
ERF deletion rescues RAS deficiency in mouse embryonic stem cells
MEK inhibition in combination with a glycogen synthase kinase-3β (GSK3β) inhibitor, referred as the 2i condition, favors pluripotency in embryonic stem cells (ESCs). However, the mechanisms by which the 2i condition limits ESC differentiation and whether RAS proteins are involved in this phenomenon remain poorly understood. Here we show that RAS nullyzygosity reduces the growth of mouse ESCs (mESCs) and prohibits their differentiation. Upon RAS deficiency or MEK inhibition, ERF (E twenty-six 2 [Ets2]-repressive factor), a transcriptional repressor from the ETS domain family, translocates to the nucleus, where it binds to the enhancers of pluripotency factors and key RAS targets. Remarkably, deletion of Erf rescues the proliferative defects of RAS-devoid mESCs and restores their capacity to differentiate. Furthermore, we show that Erf loss enables the development of RAS nullyzygous teratomas. In summary, this work reveals an essential role for RAS proteins in pluripotency and identifies ERF as a key mediator of the response to RAS/MEK/ERK inhibition in mESCs., C.M.-R. was funded by a PhD fellowship from La Caixa Foundation,
T.O. was funded by a PhD fellowship from the Boehringer
Ingelheim Fonds, and S.R. was funded by a Ramon y
Cajal contract (RYC-2011-09242). Research was funded by Fundación
Botín and Banco Santander through its Santander Universities
Global Division; grants from the Spanish Ministry of
Economy and Competitiveness (SAF2011-23753 and SAF2014-
57791-REDC; these projects were cofinanced with European
Fonds Européen de Développement Économique et Régional
[FEDER] funds), Fundació La Marato de TV3, Howard Hughes
Medical Institute, and the European Research Council (ERC-
617840) to O.F.-C.; and grants from the Spanish Ministry of Economy and Competitiveness (SAF2013-49147-P and
SAF2016-80874-P; these projects were cofinanced with European
FEDER funds) to S.R., Peer reviewed